Vizsgálati helyszín
Palmetto Retina Center
West Columbia, South Carolina 29169, Egyesült ÁllamokMég nincs intézményhez kötve
- 10futó vizsgálat
- 11lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 21 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis13 vizsgálat
- 2. fázis5 vizsgálat
- 1/2. fázis1 vizsgálat
- 2/3. fázis1 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Lezárult10 vizsgálat
- Fut, nem toboroz6 vizsgálat
- Toboroz4 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Hoffmann-La Roche4 vizsgálat
- 4D Molecular Therapeutics2 vizsgálat
- Astellas Pharma Global Development, Inc.2 vizsgálat
- Greater Houston Retina Research2 vizsgálat
- Ocular Therapeutix, Inc.2 vizsgálat
- és még 8
Futó vizsgálatok
Toboroz
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
NCT07516132· 3. fázis· Ocular Therapeutix, Inc.· Forrás
Contact: Nitin Nigam, MD
Toboroz
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
NCT07496567· 2/3. fázis· EyeBiotech Ltd.· Forrás
Contact: Study Coordinator
Toboroz
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445· 2. fázis· ONL Therapeutics· Forrás
Contact: Study Coordinator
Toboroz
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT07064759· 3. fázis· 4D Molecular Therapeutics· Forrás
Contact: 4DMT Patient Advocacy
Fut, nem toboroz
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT06864988· 3. fázis· 4D Molecular Therapeutics· Forrás
Toboroz
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
NCT06541704· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
NCT06556368· 3. fázis· Kodiak Sciences Inc· Forrás
Fut, nem toboroz
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
NCT06491914· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
NCT06223958· 3. fázis· Ocular Therapeutix, Inc.· Forrás
Fut, nem toboroz
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
NCT04108156· 3. fázis· Hoffmann-La Roche· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
NCT06172257· 3. fázis· Oculis· Forrás
Lezárult
Safety and Efficacy of Faricimab in Patients With NPDR
NCT05681884· 2. fázis· Greater Houston Retina Research· Forrás
Lezárult
A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT05839041· 2. fázis· Aviceda Therapeutics, Inc.· Forrás
Lezárult
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
NCT05642312· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
NCT05536297· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás
Lezárult
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
NCT06850922· 1/2. fázis· Genentech, Inc.· Forrás
Lezárult
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial
NCT04708145· 4. fázis· Greater Houston Retina Research· Forrás
Lezárult
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT04777201· 3. fázis· Hoffmann-La Roche· Forrás
Leállították
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
NCT04566445· 2. fázis· Gyroscope Therapeutics Limited· Forrás
Lezárult
A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm
NCT04503551· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
NCT03364153· 2. fázis· Astellas Pharma Global Development, Inc.· Forrás
Hibát jelzek